首页 > 市场调查报告书 > 医疗设备

运输/物流生技设备

市场调查报告书

商品编码

1570913

医疗保健冷链物流市场、机会、成长动力、产业趋势分析与预测，2024-2032

Healthcare Cold Chain Logistics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

出版日期: 2024年08月08日 | 出版商:

Global Market Insights Inc. | 英文 250 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2023年，全球医疗保健冷链物流市场价值为550亿美元，预计2024年至2032年复合年增长率将超过9%。严格的温度管理对于整个供应链保持产品功效至关重要，从而导致对冷链解决方案的投资增加。医疗保健物流提供者正在扩展到新的地区，增强分销网络并确保可靠的交付，这支持全球健康倡议并满足对温度敏感的医疗保健解决方案不断增长的需求。

整个医疗保健冷链物流行业根据产品、服务、温度范围、最终用户和地区进行分类。

市场依产品分为生物製药、临床试验材料、疫苗等。 2023年，生物製药占超过44%的市场。生物製药的日益突出正在推动先进温控物流解决方案的采用。复杂的监控系统，例如即时温度感测器和自动资料记录，对于保障产品完整性至关重要。增强的追踪技术确保遵守严格的法规并提高供应链的可靠性，解决生物製药分销的独特挑战。

市场依服务分为运输、储存、包装等。 2023年，运输服务约占市场份额的47%。运输服务越来越多地采用电动和混合动力汽车，以减少碳排放并提高温控物流的可持续性。这种向环保运输选择的转变补充了先进的温度管理系统，确保高效且对环境负责的温度敏感产品的交付。这种方法符合日益增长的环境法规和对绿色供应链实践的需求。

北美在全球医疗保健冷链物流市场中占据主导地位，到2023年，其主要份额约为34%。公司正在采用人工智慧驱动的温度监控和自动储存系统等先进技术来提高效率和合规性。对现代化的关注旨在满足对温度敏感产品不断增长的需求，并简化整个地区的分销流程。

产业生态系统分析
供应商格局
- 药品製造商
- 包装供应商
- 冷链物流供应商
- 冷库供应商
- 技术提供者
- 经销商
- 最终用户
利润率分析
技术与创新格局
专利分析
重要新闻和倡议
监管环境
衝击力
- 成长动力
  - 对生物製剂和疫苗的需求不断增长
  - 包装和监控方面的技术进步
  - 扩大全球药品供应链
  - 临床试验和研究活动的成长
- 产业陷阱与挑战
  - 维护冷链基础设施的成本高昂
  - 复杂的物流和温控要求
成长潜力分析
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司市占率分析
竞争定位矩阵
战略展望矩阵

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

主要趋势
生物製药
疫苗
临床试验材料
其他的

第 6 章：市场估计与预测：按服务分类，2021 - 2032 年

主要趋势
运输
贮存
包装
其他的

第 7 章：市场估计与预测：按温度范围划分，2021 - 2032 年

主要趋势
冷藏（2°C 至 8°C）
冷冻（-20°C 至 -80°C）
受控室温（15°C 至 25°C）

第 8 章：市场估计与预测：按最终用户划分，2021 - 2032 年

主要趋势
生物製药公司
医院和诊所
研究机构
其他的

第 9 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 英国
- 德国
- 法国
- 西班牙
- 义大利
- 俄罗斯
- 北欧人
- 欧洲其他地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 澳洲
- 东南亚
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地区
MEA
- 阿联酋
- 南非
- 沙乌地阿拉伯
- MEA 的其余部分

第 10 章：公司简介

American Airlines Cargo
Averitt Express
Cardinal Health
Cavalier Logistics
CEVA Logistics
Cryoport
DB Schenker
DHL International GmbH
DSV
Envirotainer
Expeditors International
FedEx Corporation
Geodis
J.B. Hunt Transport Services
Kuehne + Nagel International AG
Sinotrans Limited
Toll Group
United Parcel Service, Inc.
World Courier (a part of AmerisourceBergen)
XPO Logistics

简介目录

Product Code: 10718

The Global Healthcare Cold Chain Logistics Market was valued at USD 55 billion in 2023 and is projected to grow at a CAGR of over 9% from 2024 to 2032. The global demand for biologics and vaccines drives the need for advanced temperature-controlled logistics. Stringent temperature management is crucial throughout the supply chain to maintain product efficacy, leading to increased investments in cold chain solutions. Healthcare logistics providers are expanding into new regions, enhancing distribution networks, and ensuring reliable deliveries, which supports global health initiatives and meets the rising demand for temperature-sensitive healthcare solutions.

The overall healthcare cold chain logistics industry is classified based on the product, service, temperature range, end-user, and region.

The market is segmented by product into biopharmaceuticals, clinical trial materials, vaccines, and others. In 2023, biopharmaceuticals held over 44% of the market share. The growing prominence of biopharmaceuticals is driving the adoption of advanced temperature-controlled logistics solutions. Sophisticated monitoring systems, such as real-time temperature sensors and automated data logging, are essential to safeguard product integrity. Enhanced tracking technologies ensure compliance with stringent regulations and improve supply chain reliability, addressing the unique challenges of biopharmaceutical distribution.

The market is categorized by service into transportation, storage, packaging, and others. In 2023, transportation services accounted for around 47% of the market share. Transportation services are increasingly incorporating electric and hybrid vehicles to reduce carbon emissions and improve sustainability in temperature-controlled logistics. This shift towards eco-friendly transportation options complements advanced temperature management systems, ensuring efficient and environmentally responsible delivery of temperature-sensitive products. This approach aligns with growing environmental regulations and the demand for greener supply chain practices.

North America dominated the global healthcare cold chain logistics market, with a major share of around 34% in 2023. In North America, there is a significant push towards enhancing cold chain infrastructure through digitalization and automation. Companies are adopting advanced technologies such as AI-driven temperature monitoring and automated storage systems to improve efficiency and compliance. This focus on modernization aims to address the rising demand for temperature-sensitive products and streamline the distribution process across the region.

Chapter 1 Methodology and Scope

1.1 Research design
- 1.1.1 Research approach
- 1.1.2 Data collection methods
1.2 Base estimates and calculations
- 1.2.1 Base year calculation
- 1.2.2 Key trends for market estimates
1.3 Forecast model
1.4 Primary research and validation
- 1.4.1 Primary sources
- 1.4.2 Data mining sources
1.5 Market definitions

Chapter 2 Executive Summary

2.1 Industry 360° synopsis, 2021 - 2032

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Supplier landscape
- 3.2.1 Pharmaceuticals manufacturers
- 3.2.2 Packaging suppliers
- 3.2.3 Cold chain logistics providers
- 3.2.4 Cold storage providers
- 3.2.5 Technology providers
- 3.2.6 Distributors
- 3.2.7 End Users
3.3 Profit margin analysis
3.4 Technology and innovation landscape
3.5 Patent analysis
3.6 Key news and initiatives
3.7 Regulatory landscape
3.8 Impact forces
- 3.8.1 Growth drivers
  - 3.8.1.1 Rising demand for biologics and vaccines
  - 3.8.1.2 Technological advancements in packaging and monitoring
  - 3.8.1.3 Expansion of global pharmaceutical supply chains
  - 3.8.1.4 Growth in clinical trials and research activities
- 3.8.2 Industry pitfalls and challenges
  - 3.8.2.1 High costs of maintaining cold chain infrastructure
  - 3.8.2.2 Complex logistics and temperature control requirements
3.9 Growth potential analysis
3.10 Porter's analysis
3.11 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategic outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($Bn, 000' tons)

5.1 Key trends
5.2 Biopharmaceuticals
5.3 Vaccines
5.4 Clinical trial materials
5.5 Others

Chapter 6 Market Estimates and Forecast, By Service, 2021 - 2032 ($Bn)

6.1 Key trends
6.2 Transportation
6.3 Storage
6.4 Packaging
6.5 Others

Chapter 7 Market Estimates and Forecast, By Temperature Range, 2021 - 2032 ($Bn)

7.1 Key trends
7.2 Refrigerated (2°C to 8°C)
7.3 Frozen (-20°C to -80°C)
7.4 Controlled room temperature (15°C to 25°C)

Chapter 8 Market Estimates and Forecast, By End User, 2021 - 2032 ($Bn, 000' tons)

8.1 Key trends
8.2 Biopharmaceutical companies
8.3 Hospitals and clinics
8.4 Research Institutions
8.5 Others

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($Bn, 000' tons)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 UK
- 9.3.2 Germany
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Russia
- 9.3.7 Nordics
- 9.3.8 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 India
- 9.4.3 Japan
- 9.4.4 South Korea
- 9.4.5 Australia
- 9.4.6 Southeast Asia
- 9.4.7 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 MEA
- 9.6.1 UAE
- 9.6.2 South Africa
- 9.6.3 Saudi Arabia
- 9.6.4 Rest of MEA